APA (7th ed.) Citation

Ankathil, R. (2016). Imatinab mesylate treatment in Chronic Myeloid Leukemia (CML)- understanding the fundamental pharmacokinetic and pharmacogenetic mechanisms for variation in response. Pusat Pengajian Sains Perubatan, Universiti Sains Malaysia.

Chicago Style (17th ed.) Citation

Ankathil, Ravindran. Imatinab Mesylate Treatment in Chronic Myeloid Leukemia (CML)- Understanding The fundamental Pharmacokinetic And pharmacogenetic Mechanisms for Variation In response. Pusat Pengajian Sains Perubatan, Universiti Sains Malaysia, 2016.

MLA (9th ed.) Citation

Ankathil, Ravindran. Imatinab Mesylate Treatment in Chronic Myeloid Leukemia (CML)- Understanding The fundamental Pharmacokinetic And pharmacogenetic Mechanisms for Variation In response. Pusat Pengajian Sains Perubatan, Universiti Sains Malaysia, 2016.